697 related articles for article (PubMed ID: 19918244)
1. CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression.
Raison CL; Dantzer R; Kelley KW; Lawson MA; Woolwine BJ; Vogt G; Spivey JR; Saito K; Miller AH
Mol Psychiatry; 2010 Apr; 15(4):393-403. PubMed ID: 19918244
[TBL] [Abstract][Full Text] [Related]
2. IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity.
Wichers MC; Koek GH; Robaeys G; Verkerk R; Scharpé S; Maes M
Mol Psychiatry; 2005 Jun; 10(6):538-44. PubMed ID: 15494706
[TBL] [Abstract][Full Text] [Related]
3. [Impact of interferon alpha immunotherapy on tryptophan metabolism in patients with chronic hepatitis C. Results of a pilot studies on ten patients].
Vignau J; Costisella O; Canva V; Imbenotte M; Duhamel A; Lhermitte M
Encephale; 2009 Oct; 35(5):477-83. PubMed ID: 19853722
[TBL] [Abstract][Full Text] [Related]
4. A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate.
Heyes MP; Saito K; Major EO; Milstien S; Markey SP; Vickers JH
Brain; 1993 Dec; 116 ( Pt 6)():1425-50. PubMed ID: 8293279
[TBL] [Abstract][Full Text] [Related]
5. Effects of PEG-interferon alpha plus ribavirin on tryptophan metabolism in patients with chronic hepatitis C.
Comai S; Cavalletto L; Chemello L; Bernardinello E; Ragazzi E; Costa CV; Bertazzo A
Pharmacol Res; 2011 Jan; 63(1):85-92. PubMed ID: 20940053
[TBL] [Abstract][Full Text] [Related]
6. Activation of the kynurenine pathway and increased production of the excitotoxin quinolinic acid following traumatic brain injury in humans.
Yan EB; Frugier T; Lim CK; Heng B; Sundaram G; Tan M; Rosenfeld JV; Walker DW; Guillemin GJ; Morganti-Kossmann MC
J Neuroinflammation; 2015 May; 12():110. PubMed ID: 26025142
[TBL] [Abstract][Full Text] [Related]
7. Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms.
Schefold JC; Zeden JP; Fotopoulou C; von Haehling S; Pschowski R; Hasper D; Volk HD; Schuett C; Reinke P
Nephrol Dial Transplant; 2009 Jun; 24(6):1901-8. PubMed ID: 19155537
[TBL] [Abstract][Full Text] [Related]
8. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease.
Heyes MP; Saito K; Crowley JS; Davis LE; Demitrack MA; Der M; Dilling LA; Elia J; Kruesi MJ; Lackner A
Brain; 1992 Oct; 115 ( Pt 5)():1249-73. PubMed ID: 1422788
[TBL] [Abstract][Full Text] [Related]
9. Inter-relationships between quinolinic acid, neuroactive kynurenines, neopterin and beta 2-microglobulin in cerebrospinal fluid and serum of HIV-1-infected patients.
Heyes MP; Brew BJ; Saito K; Quearry BJ; Price RW; Lee K; Bhalla RB; Der M; Markey SP
J Neuroimmunol; 1992 Sep; 40(1):71-80. PubMed ID: 1387655
[TBL] [Abstract][Full Text] [Related]
10. The kynurenine pathway and inflammation in amyotrophic lateral sclerosis.
Chen Y; Stankovic R; Cullen KM; Meininger V; Garner B; Coggan S; Grant R; Brew BJ; Guillemin GJ
Neurotox Res; 2010 Aug; 18(2):132-42. PubMed ID: 19921535
[TBL] [Abstract][Full Text] [Related]
11. Neurotoxic and neuroprotective metabolites of kynurenine in patients with renal cell carcinoma treated with interferon-alpha: course and relationship with psychiatric status.
Van Gool AR; Verkerk R; Fekkes D; Bannink M; Sleijfer S; Kruit WH; van der Holt B; Scharpé S; Eggermont AM; Stoter G; Hengeveld MW
Psychiatry Clin Neurosci; 2008 Oct; 62(5):597-602. PubMed ID: 18950381
[TBL] [Abstract][Full Text] [Related]
12. HTR1A, TPH2, and 5-HTTLPR Polymorphisms and Their Impact on the Severity of Depressive Symptoms and on the Concentration of Tryptophan Catabolites during Hepatitis C Treatment with Pegylated Interferon-α2a and Oral Ribavirin (PEG-IFN-α2a/RBV).
Pawlowski T; Malyszczak K; Pawlak D; Inglot M; Zalewska M; Grzywacz A; Radkowski M; Laskus T; Janocha-Litwin J; Frydecka D
Cells; 2023 Mar; 12(6):. PubMed ID: 36980311
[TBL] [Abstract][Full Text] [Related]
13. Activation of central nervous system inflammatory pathways by interferon-alpha: relationship to monoamines and depression.
Raison CL; Borisov AS; Majer M; Drake DF; Pagnoni G; Woolwine BJ; Vogt GJ; Massung B; Miller AH
Biol Psychiatry; 2009 Feb; 65(4):296-303. PubMed ID: 18801471
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid kynurenines in multiple sclerosis; relation to disease course and neurocognitive symptoms.
Aeinehband S; Brenner P; Ståhl S; Bhat M; Fidock MD; Khademi M; Olsson T; Engberg G; Jokinen J; Erhardt S; Piehl F
Brain Behav Immun; 2016 Jan; 51():47-55. PubMed ID: 26189678
[TBL] [Abstract][Full Text] [Related]
15. Associations among peripheral and central kynurenine pathway metabolites and inflammation in depression.
Haroon E; Welle JR; Woolwine BJ; Goldsmith DR; Baer W; Patel T; Felger JC; Miller AH
Neuropsychopharmacology; 2020 May; 45(6):998-1007. PubMed ID: 31940661
[TBL] [Abstract][Full Text] [Related]
16. Involvement of the kynurenine pathway in human glioma pathophysiology.
Adams S; Teo C; McDonald KL; Zinger A; Bustamante S; Lim CK; Sundaram G; Braidy N; Brew BJ; Guillemin GJ
PLoS One; 2014; 9(11):e112945. PubMed ID: 25415278
[TBL] [Abstract][Full Text] [Related]
17. Associations between circulating interferon and kynurenine/tryptophan pathway metabolites: support for a novel potential mechanism for cognitive dysfunction in SLE.
Anderson EW; Jin Y; Shih A; Arazi A; Goodwin S; Roeser J; Furie RA; Aranow C; Volpe B; Diamond B; Mackay M
Lupus Sci Med; 2022 Nov; 9(1):. PubMed ID: 36384965
[TBL] [Abstract][Full Text] [Related]
18. Exercise and the Kynurenine pathway: Current state of knowledge and results from a randomized cross-over study comparing acute effects of endurance and resistance training.
Joisten N; Kummerhoff F; Koliamitra C; Schenk A; Walzik D; Hardt L; Knoop A; Thevis M; Kiesl D; Metcalfe AJ; Bloch W; Zimmer P
Exerc Immunol Rev; 2020; 26():24-42. PubMed ID: 32139353
[TBL] [Abstract][Full Text] [Related]
19. Effect of immune activation on the kynurenine pathway and depression symptoms - A systematic review and meta-analysis.
Hunt C; Macedo E Cordeiro T; Suchting R; de Dios C; Cuellar Leal VA; Soares JC; Dantzer R; Teixeira AL; Selvaraj S
Neurosci Biobehav Rev; 2020 Nov; 118():514-523. PubMed ID: 32853625
[TBL] [Abstract][Full Text] [Related]
20. Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment.
Capuron L; Neurauter G; Musselman DL; Lawson DH; Nemeroff CB; Fuchs D; Miller AH
Biol Psychiatry; 2003 Nov; 54(9):906-14. PubMed ID: 14573318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]